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Abstract 
Back ground:  Anti-retroviral therapy (ART) is a treatment for people living with HIV to help them to attain a 
maximal and durable suppression of the viral replication and prevention of the resistance. ARV regimens require 
adherence rate of at least 95.0% to achieve undetectable viral load, reduce the risk of drug-resistant HIV 
development and minimize recurrence of symptoms of AIDS. This study is aimed improve the information gap 
regarding adherence level and factors predicting the adherence of people to ART attending clinics of hospitals in 
west shoa zone of Oromia regional state, Ethiopia.Objectives: This is designed to identify predictors of ART 
adherence among people living with HIV and following ART treatment at hospitals in West Shewa Zone of 
Oromia Region, Ethiopia.Methodology:  data for the study is conducted from January to March 2015. at public 
hospitals found in West Shewa Zone of Oromia Region. A cross sectional study design that includes quantitative 
and qualitative study type was employed. Participants were selected by computer generated simple random 
sampling method. The collected data was cleansed, edited, coded, entered to SPSS version 16.0 window and 
analyzed.  Multiple logistic regressions model is used to identify the predicting factors of ART adherence. Result: 
A total of 326 people living with HIV/AIDS were participated in the study. From the participated clients, 66.2% 
of them achieved the recommended high level adherence. Being a jobless (has no job) (AOR= 0.005, 95% CI= 
0.035-0.559), being on ART for 12-24 months (AOR= 8.9, 95% CI=2.816-28.0556), good knowledge of the 
importance of ART drug (AOR= 0.039, 95% CI=0.019-0.079) and being bored with drug consumption 
sometimes only (AOR=2.718, 95% CI=1.077-6.860) are factors significantly independently predicting ART 
adherence among people living with human immune virus. Traveling distance, felt depressed at dosing time, 
being busy with other work and long distance to facility were among the participants reason for not taking doses 
but these are not significantly associated with the adherence rate. Conclusion and Recommendation: From this 
study it was seen that ART adherence is not satisfactory to achieve the intended treatment outcome. 
Occupational status, duration of ART usage, knowledge of ART benefit and being bored with drug consumption 
are the statically significant predictors of ART adherence. So that ART treatment adherence enhancing program 
should target the client’s knowledge of the importance of the drugs, personal behaviors and work condition of 
the community. 
Keywords: ART, PLHIV, drug adherence. 
 
1. INTRODUCTION   
HIV/AIDS prevention and control was recognized as a top priority health intervention from the start of health 
service development program one (HSDP I) in 1996/7 and the program is sustained up to health service 
development program four(HSDP IV) of 2010/11 in Ethiopia (1). Accessibility of ART drug was considered in 
the health sector development plan. Antiretroviral Therapy (ART) is treatment for AIDS that helps the body’s 
immune system recover from the damage caused by infection with HIV. Although ART cannot cure AIDS, 
persons on ART will begin to feel better, eat more, and put on weight. Their bodies will recover the ability to 
fight infections (2, 3). As persons on ART treatment become well, they can care for their children and return to 
household activities and productive life, which benefits the household and national economies (4). It is seen in 
deferent studies that the general clinical stage of the patients on ART has shown an improvement (5). 
For counteracting the impact of HIV on economy, WHO first produced global guidelines on the use of 
ARVs for HIV treatment in 2002, followed by guidelines on the use of ARVs for preventing mother-to-child 
transmission of HIV in 2004(6). Following this Ethiopia also developed guidelines for implementation of ART 
in Ethiopia in 2007, since that it is implemented by providing the drug free of charge despite the adherence 
challenges observed (7).  Management of HIV disease includes prevention and treatment of opportunistic 
infections (OIs) and controlling viral replication with Anti Retroviral Drugs (ARVDs) as Highly Active 
Antiretroviral Therapy (HAART)(8). 
In general the goal of anti-retroviral therapy (ART) is to attain maximal and durable suppression of the 
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viral replication. Effective ART should restore and/or preserve immunologic function. ARV regimens require 
optimal adherence to achieve undetectable viral loads and to avoid viral resistance. Adherence can be described 
as taking pharmaceuticals according to the medical standards after a voluntary agreement has been made 
between the patient and the health care provider (9). Adherence is a major predictor of the survival of individuals 
living with HIV (10). An adherence rate of at least 95.0% is necessary to maximize the benefits of antiretroviral 
therapy (ART) (11).  
However there is limited documentation of adherence amongst patients on ART in the west shoa of 
west Oromia, Ethiopia. The current study will identify the adherence level of PLHIV with ART drug and 
personal factors predicting the ART adherence which will help care providers, HIV programmers and other stake 
holders to consider such factors in their programs and strategies. The study focuses self report-based adherence 
measures. 
 
2. Objectives  
General objectives  
• To identify the factors predicting adherence to antiretroviral therapy among people living with HIV 
attending ART clinics of hospitals in west Shewa zone in Oromia region, Ethiopia 2015. 
Specific objectives 
• To determine the level of ART  drugs adherence among PLHIV attending ART clinic in public 
hospitals 
• To identify factors predicting ART adherence among PLHIV attending treatment at ART clinic in 
public hospitals 
 
3. Methodology and materials  
3.1. Study area and period  
The study was conducted from January, 2014 to March, 2014 G.C. at hospitals found in West Shewa Zone, 
Oromia Regional state, Ethiopia. In west Shewa zone there are three hospitals that have ART clinic. These are 
Ambo hospital which is found in Ambo town the capital of west shewa zone, Gindeberet Hospital found in 
Gindeberet district at the northern part of west shewa and Gedo hospital which is found in the capital of chellia 
district to the west of west shewa zone.  
Study design: Cross sectional study which includes both quantitative and qualitative data collection  
Population: The source population is all people living with HIV (PLHIV) and attending follow up clinics 
whereas the study population is sampled clients living with HIV (PHIV) attending the clinics in the hospitals 
found in west shewa zone. For the qualitative data people living with HIV who were not participated in the 
quantitative study were interviewed.  
Sample size and sampling technique: The sample size for the quantitative data was calculated by using a 
formula for estimating a single population proportion. An estimate of 72% is taken from the previous study 
result. By considering the non response rate 10% of the final sample is added. Totally 340 PLHIV will be 
selected. 
Computer generated random sampling technique was used by using the registration book of ART clinic 
of each hospital. The qualitative data was collected from PLHIV working in the HIV related associations or 
organizations and attending ART clinics at the same study areas. 
Data collection instruments are adapted from different literatures that have been used by different 
studies done both in Ethiopia and out of Ethiopia. The tools were edited according to the objectives of the study. 
Health professionals who have taken a one day extensive training regarding the data collection 
conducted a self reported adherence exit interview. 
 
3.2. Variables  
 Independent variables  
• Socio demographic variables, Drug regimen related variables, Health problems related variables and 
Socio-cultural drug use related variables 
 Dependent variable  
 ART drug dose adherence 
 Time of dose adherence 
 
3.3. Operational definition  
 Good adherence: Clients those who take > 95% of the prescribed drug as recommended by the health care 
provider within the last one week before the date of interview is categorized under good adherence. 
 Poor adherence: Clients those who take < 95% of the prescribed drug as prescribed by the health care 
provider within the last one week before the date of interview. 
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 Good knowledge: Participants those who answer knowledge questions above the mean are considered to 
have good knowledge. 
 Poor knowledge: Clients those who answer below the mean of knowledge question are considered to have 
poor knowledge of the benefits of ART drug. 
 
3.4. Data processing and analysis procedures 
Data is processed by using SPSS soft ware version 16.0. Collected data was checked for the assumptions like 
normality and multi collinearly for all variables. Descriptive statistics was done first to understand the general 
distribution of the respondents. Binary logistic regression was used to check level of association between each 
dependent and independent variable. Variable which are associated at significant level of less than 0.25 (p<0.25) 
was taken to the multiple variable binary logistic regression to see the predictive tendency of the independent 
variables. The results were interpreted using odds ratios and confidence intervals. 
The data collected for the qualitative study was analyzed after grouping the information under the focus areas 
primarily identified from the quantitative data analysis. The result of the analysis or the output was presented in 
narratives in triangulation to quantitative data using well- said verbatim of the study participants as illustrations. 
Quality assurance: The data collection tool was pretested on ten percents of the sample size one month before 
the date of actual data collection on similar population. Reliability of the tool is checked by calculating cronbach 
alpha. The tools were edited and modified after pre test and reliability test according to the objectives of the 
study. 
Ethical issues: Official letter of support was written to the study areas before the actual data collection date. 
Furthermore oral consent was obtained from the respondents immediately before the interview started. The 
participants’ right to refuse or interrupt the interview was secured. 
 
4. Result  
4.1. Socio demographic characteristics of PLHIV 
From the total 326 ART attendants have participated in the study which shows a response rate of 95.9% among 
which 210(64.4%) female. Majority 143(43.9%) and 85(26.1%) of them fall in 35-44, 26-34 years age group 
respectively. Regarding the marital status, 187(57.4%) were married whereas, 36(11%), 53(16.3%), and 
50(15.3%) were single, divorced and widowed respectively. Majority of the study participants, 172(52.8%) were 
orthodox religion followers followed by protestants 138(42.3%). Oromo 287(88%) and Amhara 35(10.7%) 
ethnic group are dominant in number. Majority 134(41.1%) of the participants have attended elementary school 
and only 24(7.4%) were learned at college and above. From the total 159(48.8%) of the participants has no job. 
Regarding the living arrangements 270(82.2%) of the study participants live with families. The average monthly 
income of 188(57.5%) of participants is less than 500 Ethiopian birr. 183(56.1%) relied on self for living where 
as 106(32.5%) were dependent on family. 212(65%) of participants live in urban area where as the rest of the 
participants live in rural area.  
ART Drug related information about PLHIV in the study area: Around half, 165(50.6%) have been on ART 
drug for more than 24 months. The CD4 count of 136(41.7%) of the participants during study period was greater 
than 500mm3 and it is less than 200mm3 for 51(15.6%) of them. The CD4 count at which the ART started 
was >=500mm3 for 14(4.3%) and <200mm3 for 199(61%) of the participants. Again when the ART started 
60(18.4%) of participants fall in WHO clinical stage I and 15(4.6%) of them fall in clinical stage IV. During the 
data collection period, 138(42.3%) of the study participants fall in WHO clinical stage I where as 2(0.6%) fall in 
clinical stage IV. Study participants who first disclosed their HIV status to their spouse were 173(53.1%). Others 
20(6.1%), 34(10.4%), 23(7.1%), and 76(23.3%) first disclosed their serum HIV status to their mother/father, 
brother/sister, friends and others respectively. Majority 229(70.2%), of the study participants obtained emotional 
support from the person for whom they disclosed their HIV status. Regarding the source of support, 241(73.9%) 
of the study participants relied on their own selves 50(15.3%), 24(7.4%) and 11(3.4%) dependent on family, 
government and NGOS respectively.  
ART drugs behaviors from self report: Regarding drug related behaviors from the self report, 320(98.2%) of 
participants continue use of drug always, 271(83.1%) go to see their care provider for health check up and 
receive the drug on time always, 281(86.2%) take ART drug with every meal as prescribed always, 311(95.4%) 
of participants never increase or decrease ART drug dose when feeling better or bad, 315(96.6%) of the clients 
never stop taking ART drug when having adverse effect without consulting their health care provider, 7(2.1%) of 
the study participants always forget to take their drugs with them when traveling distance, 323(99.07%) clients 
never take ART drugs with herbal medicine, 171(25.2%) never read the label of the container before taking the 
drug, 285(87.4%) use clock always, 225(69%) never bored to comply the drug fully, 13(4%) forget to take the 
drug within half an hour of the intended time, 94(28.8%), counts the pills after taking always. 
Socio-cultural drug use: Concerning the use of behavioral drug, 45(13.8%) of the study participants use alcohol 
where as chat is used by only 4(1.2%). 
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Knowledge of ART drug among PLHIV: From the total participants 183(56.1%) scored more than mean score 
of the knowledge questions and considered to have good knowledge The specific questions and the participants 
response is indicated in the following table.  
Adherence to ART drug: From the total participants 127(39.9%) have missed at least one doses of drugs in the 
last two weeks prior to date of data collection among which majority, 80(62.99%) missed three ART doses. 
Concerning the dose time, 259(79.4%) took the tablets on time where as only 67(20.6%) took the drug without 
considering the scheduled time for the specific drug. 
Regarding the adherence, 216(66.3%) of the PLHIV have achieved the high level dose adherence where as 
67(20.6%) of the total participants took the drug without considering the schedule of the dose. The following 
table shows the distribution of the dose and time adherence. 
Reasons for not taking the drug as scheduled: Forgetting to take the doses of drug 33 (10.1%), being busy 
with other work 30(9.2%), felt depressed 29(8.9%), long distance to facility 28(8.6%) and have no enough food 
to take the drug were the identified reasons to not consider the dose schedule. 
 
4.2. Predictors of ART adherence among PLWH 
Predictors of dose adherence  
From the identified variables being a jobless (has no job) (AOR= 0.233, 95% CI= 0.086-0.633), being on ART 
for 3-12 months (AOR= 4.920, 95% CI=2.199-11.012), having good knowledge of the importance of ART drug 
(AOR= 0.039, 95% CI=0.019-0.079) and being bored with drug consumption sometimes only (AOR=2.718, 
95% CI=1.077-6.860), are the independent factors significantly associated with ART adherence. 
This result is also supported by the qualitative information’s. According to the response it is obvious that many 
of the PLHIV consume the drug because of its health benefits. As an example a 54 years mothers supportive 
group member at Ambo health center said that, I can practically tell you that many of the people are benefitted 
from the drugs, when people comes and linked to the ART most of them are chronically sick but after some 
months, their AIDS symptoms disappears. 
Factors affecting ART drug time adherence 
Forgetting to take drug when traveling distance (AOR=0.124, 95% CI=0.028-0.533), having good knowledge of 
ART importance, (AOR=0.247, 95% CI=0.127-0.482), and increasing or decreasing ART dose without 
consulting care provider when having disease symptoms (AOR=0.134, 95% CI=0.021-0.852) are the 
independent factors affecting adherence to ART dose time. This finding is supported by most of in-depth 
interview discussants, for instance: − as one discussant explained that “those who knows the benefits of the drug 
adheres themselves to the dose schedules, but in contrary to this there are reluctant(gidiyelesh) people who take 
the drug only when their conditions are worsened, even they discontinue”. 
 
5. Discussion  
From the finding it is understandable that 66.3% (95% CI=62- 71.5) of the study population has achieved the 
recommended (95% or more) adherence rate. That means that 66.3% of participants missed not more than one (1) 
does during their recall time or 7 days before the date of data collection. This finding is lower when compared to 
studies conducted in Jimma university specialized teaching hospital and Yirgalem hospital in Ethiopia (12,13) 
and in Senegal(14) from abroad, it is similar with findings from studies conducted in Togo(15) but significantly 
higher when compared to findings from south Nigeria, Zambia and Benin(16,17,18). This findings justifies the 
reality that the ATR adherence rate among Sub Saharan African countries have more of less similar picture and 
still it needs an attention to achieve the intended goal of ART provision in all areas(19).  
Regarding the factors predicting adherence to ART regimen the study have identified that, being jobless, 
having good knowledge of the benefits of ART and being bored with ART dose only sometimes are statistically 
significantly associated with ART adherence. In other way a study conducted at Jimma University specialized 
teaching hospital, west Ethiopia, and Yirgalem district hospital(12,13), have revealed that support obtained from 
family and being dependent on family was significant factor related to ART dose, time and food adherence. This 
means that more or less socioeconomic factors similarly predicts ART adherence rate in different parts of 
Ethiopia. In addition outside Ethiopia, the study from West Africa Togo has also identified some similar factors 
affecting ART drug adherence. These all insures that, the barriers to ART adherence and follow up identified in 
the study conducted at India which includes unemployment, economic dependent and behavior towards 
medication (20).  
The current study participants have different reasons for non adherence to both dose and time adherence, 
such as simply forgetting to take the doses of drug 10.1%, being busy with other work 9.2%, felt depressed 8.9%, 
long distance to facility 8.6% and have no enough food to take the drug were the identified reasons orderly. 
These reasons were almost similar with the findings of the studies western Ethiopia specifically Jimma 
University specialized teaching hospital and Yirgalem hospital, and from other African countries (12, 13, 16). 
The similarity may be because of the socioeconomic characteristics of the participants or similarity of the study 
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area set up as both the current and previous studies used hospitals. A field based observational longitudinal study 
conducted in Zambia identified long distance to health facilities, food insufficiency, and being busy with other 
activities (18) but in the current study distance was not an issue to not adhere to the drug schedule. Despite the 
difference in method of study, this may show success in the HIV/AIDS service decentralization plan of health 
care system in Ethiopia. A study conducted in south Nigeria also identified forgetting and other as a common 
reason of non adherence in addition to what is identified above (16). The similarity may be from the 
socioeconomic characteristics of the PLHIV.   
Regarding the dose time adherence the current study have identified adherence rate of 79.4%, which is 
higher when compared to what was identified in the study conducted in western Ethiopia at Jimma university 
specialized teaching hospital (12). Similar reasons were identified as in the case of dose adherence above. 
Having good knowledge of the benefits of ART drug again statistically significantly predicts drug dose time 
adherence and is similar with the findings of other studies from Jimma which is because of the similarities in 
terms of different characteristics. 
Generally the adherence rate finding of the current study falls in the range of the findings from the 
previous studies in different African countries. The reasons for non adherence are also somewhat similar with the 
report of those studies. Regarding the factors affecting ART drug adherence among PLHIV the current study 
have identified factors that almost overlap with the previous studies conducted in other parts of Ethiopia 
specifically Jimma and Yirgalem western Ethiopia (12,13). 
 
6. Conclusion and recommendations  
1. The current study have identified poor ART drug adherence rate among people living with HIV in 
comparison with the recommended adherence rate to suppress viral load and prevent drug resistance. 
Zonal health department, hospitals, regional health bureau and concerned bodies to the HIV prevention 
and control should make an effort to enhance the ART adherence rate. 
2. Work conditions, knowledge about the benefits of ART were the significant factors in affecting ART 
adherence. So that to improve the current drug adherence level among PLHIV, the district health offices, 
zonal health departments and other concerned NGOs should attempt to improve ART provision that 
target the socioeconomic condition of the PLHIV. In addition the health care team of the hospitals 
should intensify their information to improve the client’s knowledge of the benefits of ART drug 
adherence.  
3. Duration of ART consumption and personal behaviors related to drug consumption were among the 
factors significantly affecting the drug adherence rate. This is also true in other documents that Good 
adherence frequently wanes over time, and patients may need significant support the longer the duration 
of therapy. This also needs the attention of the health care team. Health care providers should use 
different strategies such as maintain open discussion with their clients and helping clients to have an 
informed decision about the drug adherence. 
4. As a limitation this study did not included social/community and or health facility related predictors, 
doe to this the next research should attempt to address this issues. 
5. Finally other researchers should work to identify the trends of ART adherence and its outcome in 
relation to the different factors identified and convince the users and health care workers that the 
identified factors contribute to the adherence rate. 
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Tables  
 
Table:  Distribution of ART adherence among PLHIV attending ART clinic at hospitals in west shoa zone, 
Oromia 2015. 
 Frequency  Percent (%) 95% CI 
Lower Upper 
Level of adherence Poor  110 33.7 28.5 39 
Good  216 66.3 62 71.5 
Total 326 100.0 100.0 100.0 
Doses taken un 
timely 
Yes  67 20.6 16 25.2 
No  259 79.4 74.8 84 
Total  326 100 100 100 
 
Table 2: Factors associated with ART adherence in PLHIV attending ART clinic at hospitals in west shoa zone, 
oromia region 2015 
Variables  Sig. AOR 95.0% C.I. 
Lower Upper 
Occupation  Others  .003    
 Employed  .477 .590 .138 2.526 
Daily laborer .771 .840 .259 2.720 
Has no job .004 .233 .086 .633 
Source of income Government  .658    
Relied on self   .796 1.229 .257 5.868 
Family  .455 1.913 .348 10.504 
NGO .692 .590 .043 8.041 
Duration ART >24 months  .000    
 3- 12 months  .000 4.920 2.199 11.012 
 12.1-24 months .612 1.241 .539 2.858 
Bored with drug Never  .101    
Always  .511 1.421 .498 4.056 
Some times  .034 2.718 1.077 6.860 
KNOWLEDGECAT Good knowledge .000 .039 .019 .079 
Poor knowledge  .000    
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Table 3: Factors affecting ART drug time (schedule) adherence time among PLHIV attending ART clinic at 
hospitals in west shoa, oromia, 2015. 
Variables P value  AOR 95.0% C.I. 
Lower Upper 
Bored with drug consumption  Never  .238    
Always  .090 2.640 .859 8.120 
Some times  .936 1.050 .318 3.469 
Take ART on time as scheduled  Never  .416    
Always  .185 .083 .002 3.301 
Some times  .261 .118 .003 4.915 
Forget ART when traveling 
distance  
Never  .014    
Always  .253 .338 .053 2.168 
Some times  .006 .124 .028 .553 
Knowledge of ART benefit Good knowledge  .000 .247 .127 .482 
 
